Jena Germany — Analytik Jena AG is the world’s first company to bring to the market a kit with CE-IVD certification for the molecular diagnostic quantification of hepatitis delta virus (HDV) RNA, thus reaching a major new milestone in the standardization of HDV nucleic acid amplification tests. The Jena-based company is building on years of […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted a 510(k) application to the FDA for the company’s NxTAG® Respiratory Pathogen Panel. This panel is the only respiratory assay that will easily enable laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system in a format that scales […]
Framingham, MA — SCIEX, a global leader in life science analytical technologies, announced today that Aarhus University Hospital in Denmark has invested in SCIEX QTRAP® 6500 technology to develop novel mass spectrometry-based assays for clinical research laboratories. Scientists at the hospital’s Department of Clinical Biochemistry are using the QTRAP 6500 LC-MS/MS system for advanced clinical […]
InDevR Collaborating with Scientists at St. Jude Children’s Research Hospital to Evaluate FluChip-8G
BOULDER, Colorado –– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced today that the lab of Richard Webby, Ph.D., at St. Jude Children’s Research Hospital (St. Jude) will be aiding in the development of a new influenza diagnostic, including evaluating assay performance on non-seasonal influenza viruses. The FluChip-8G […]
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized on its leading bioinformatics software platform in order to rapidly launch its BRCA1/2 genomic testing program. MDL, based in Covington, KY, will utilize the PierianDx Clinical Genomicist Workstation™ 3.0 to jump-start its BRCA testing program. […]
Cambridgeshire, UK — Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology1 to Roche. Roche has signed a definitive Asset Purchase Agreement with Lumora for products associated with its proprietary nucleic acid Heat Elution purification technology that is designed […]
PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution. Today, […]
Glasgow, United Kingdom – Renishaw Diagnostics is pleased to announce the launch of the CE-IVD certified RenDx Multiplex Assay System together with its first assay, Fungiplex, a multiplex PCR in vitro test for the qualitative detection of Candida and Aspergillus DNA extracted from blood samples. The assay is designed for use on the RenDx Multiplex […]
GUANGZHOU, China & SAN DIEGO – Burning Rock and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications for molecular diagnostics in oncology based on Illumina’s next-generation sequencing (NGS) technology. The collaboration highlights the ever-increasing importance of genomics to improve healthcare in China. In […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) today announced the launch of its MX-ICP EGFR Analysis lung cancer panel that covers key actionable mutations while providing precision detection levels down to as low as 0.01%. The panel uses Transgenomic’s Multiplexed ICE COLD-PCR™ (MX-ICP) technology, which generates highly accurate results from small amounts of blood or […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
